| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.66B | $8.94B | $10.66B |
| YoY Revenue Growth % | -3.1% | -16.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.13B | $1.58B | $2.86B |
| Operating Margin % | 13.1% | 17.7% | 26.9% |
| Net Income (GAAP) | $1.24B | $1.13B | $2.08B |
| EBITDA (Normalized) | $2.85B | $3.42B | $3.25B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.65B | $3.72B | $4.17B |
| Capital Expenditures (CapEx) | $2.15B | $2.30B | $479.7M |
| Free Cash Flow (FCF) | $1.50B | $1.42B | $3.69B |
| FCF Margin % | 17.4% | 15.9% | 34.6% |
| Return on Invested Capital (ROIC %) | 5.7% | 8.2% | 29.3% |
| Cash & Short-Term Equivalents | $35.0M | $42.0M | — |
| Total Debt (Short + Long Term) | $4.39B | $4.85B | $2.99B |
| Total Stockholders' Equity | $11.20B | $10.33B | $6.14B |